These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Targeted gene transfer to nigrostriatal neurons in the rat brain by helper virus-free HSV-1 vector particles that contain either a chimeric HSV-1 glycoprotein C-GDNF or a gC-BDNF protein. Wang X; Kong L; Zhang GR; Sun M; Geller AI Brain Res Mol Brain Res; 2005 Sep; 139(1):88-102. PubMed ID: 15993510 [TBL] [Abstract][Full Text] [Related]
6. HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells. Johnston KM; Jacoby D; Pechan PA; Fraefel C; Borghesani P; Schuback D; Dunn RJ; Smith FI; Breakefield XO Hum Gene Ther; 1997 Feb; 8(3):359-70. PubMed ID: 9048203 [TBL] [Abstract][Full Text] [Related]
8. Gene transfer into hepatocytes mediated by herpes simplex virus-Epstein-Barr virus hybrid amplicons. Müller L; Saydam O; Saeki Y; Heid I; Fraefel C J Virol Methods; 2005 Jan; 123(1):65-72. PubMed ID: 15582700 [TBL] [Abstract][Full Text] [Related]
9. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors. Fraefel C; Jacoby DR; Lage C; Hilderbrand H; Chou JY; Alt FW; Breakefield XO; Majzoub JA Mol Med; 1997 Dec; 3(12):813-25. PubMed ID: 9440115 [TBL] [Abstract][Full Text] [Related]
10. Plasmid DNA sequences present in conventional herpes simplex virus amplicon vectors cause rapid transgene silencing by forming inactive chromatin. Suzuki M; Kasai K; Saeki Y J Virol; 2006 Apr; 80(7):3293-300. PubMed ID: 16537596 [TBL] [Abstract][Full Text] [Related]
11. Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo. Lilley CE; Groutsi F; Han Z; Palmer JA; Anderson PN; Latchman DS; Coffin RS J Virol; 2001 May; 75(9):4343-56. PubMed ID: 11287583 [TBL] [Abstract][Full Text] [Related]
12. Genetic engineering of herpes simplex virus and vector genomes carrying loxP sites in cells expressing Cre recombinase. Logvinoff C; Epstein AL Virology; 2000 Feb; 267(1):102-10. PubMed ID: 10648187 [TBL] [Abstract][Full Text] [Related]
13. An efficient selection system for packaging herpes simplex virus amplicons. Zhang X; O'Shea H; Entwisle C; Boursnell M; Efstathiou S; Inglis S J Gen Virol; 1998 Jan; 79 ( Pt 1)():125-31. PubMed ID: 9460933 [TBL] [Abstract][Full Text] [Related]
14. Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome. Saeki Y; Fraefel C; Ichikawa T; Breakefield XO; Chiocca EA Mol Ther; 2001 Apr; 3(4):591-601. PubMed ID: 11319922 [TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo. Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477 [TBL] [Abstract][Full Text] [Related]
16. Expression of hepatitis C virus envelope glycoproteins by herpes simplex virus type 1-based amplicon vectors. Tsitoura E; Lucas M; Revol-Guyot V; Epstein AL; Manservigi R; Mavromara P J Gen Virol; 2002 Mar; 83(Pt 3):561-566. PubMed ID: 11842251 [TBL] [Abstract][Full Text] [Related]
17. Integration of active human beta-galactosidase gene (100 kb) into genome using HSV/AAV amplicon vector. Oehmig A; Cortés ML; Perry KF; Sena-Esteves M; Fraefel C; Breakefield XO Gene Ther; 2007 Jul; 14(14):1078-91. PubMed ID: 17460718 [TBL] [Abstract][Full Text] [Related]
18. Optimal purification method for Herpes-based viral vectors that confers minimal cytotoxicity for systemic route of vector administration. Sia KC; Wang GY; Ho IA; Khor HY; Miao L; Hui KM; Lam PY J Virol Methods; 2007 Feb; 139(2):166-74. PubMed ID: 17074404 [TBL] [Abstract][Full Text] [Related]
19. Combined HSV-1 recombinant and amplicon piggyback vectors: replication-competent and defective forms, and therapeutic efficacy for experimental gliomas. Pechan PA; Herrlinger U; Aghi M; Jacobs A; Breakefield XO J Gene Med; 1999; 1(3):176-85. PubMed ID: 10738566 [TBL] [Abstract][Full Text] [Related]
20. Early STAT1 activation after systemic delivery of HSV amplicon vectors suppresses transcription of the vector-encoded transgene. Suzuki M; Chiocca EA; Saeki Y Mol Ther; 2007 Nov; 15(11):2017-26. PubMed ID: 17653098 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]